Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 3520
116th Congress(2019-2020)
Stem Cell Therapeutic and Research Reauthorization Act of 2019
Introduced
Introduced
Introduced in House on Jun 26, 2019
Overview
Text
Introduced in House 
Jun 26, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Jun 26, 2019)
Jun 26, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 3520 (Introduced-in-House)


116th CONGRESS
1st Session
H. R. 3520


To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

June 26, 2019

Mr. Smith of New Jersey (for himself and Mr. Bilirakis) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Stem Cell Therapeutic and Research Reauthorization Act of 2019”.

SEC. 2. Reauthorization of the C.W. Bill Young Cell Transplantation Program.

(a) In general.—Section 379(d)(2)(B) of the Public Health Service Act (42 U.S.C. 274k(d)(2)(B)) is amended—

(1) by striking “including remote collection, consistent with the inventory” and inserting “including collection, consistent with the inventory”; and

(2) by inserting “including remote collection,” before “consistent with the requirements”.

(b) Advisory council meetings.—Subsection (a) of section 379 of the Public Health Service Act (42 U.S.C. 274k) is amended by adding at the end the following new paragraph:

“(7) The Secretary shall convene the Advisory Council at least two times each calendar year.”.

(c) Authorization of appropriations.—Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended by striking “$33,000,000 for fiscal year 2015 and $30,000,000 for each of fiscal years 2016 through 2020” and inserting “$30,000,000 for each of fiscal years 2020 through 2024”.

SEC. 3. Cord blood inventory.

Subsection (g) of section 2 of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended to read as follows:

“(g) Authorization of appropriations.—To carry out this section, there is authorized to be appropriated $23,000,000 for each of fiscal years 2020 through 2024.”.